Sitagliptin
Sitagliptin Adamed contains the active substance sitagliptin, which belongs to a group of medicines called DPP-4 inhibitors (dipeptidyl peptidase-4 inhibitors), which lower blood sugar levels in adults with type 2 diabetes.
This medicine helps increase the amount of insulin produced after a meal and also lowers the amount of sugar produced by the body.
Your doctor has prescribed this medicine to help lower your blood sugar levels, which are high due to type 2 diabetes. This medicine can be used alone or in combination with other medicines that lower blood sugar levels (insulin, metformin, sulfonylurea derivatives, or glitazone), which you may already be taking for your diabetes, along with diet and exercise.
What is type 2 diabetes?
Type 2 diabetes is a condition in which the body does not produce enough insulin, and the insulin produced does not work as well as it should. The body may also produce too much sugar. This can lead to serious health problems, such as heart disease, kidney disease, loss of vision, and amputation of limbs.
In patients taking sitagliptin, cases of pancreatitis (inflammation of the pancreas) have been observed (see section 4).
The appearance of blisters on the skin may be a sign of a disease called bullous pemphigoid.
Your doctor may advise you to stop taking Sitagliptin Adamed.
You should inform your doctor if you have or have had:
Children and adolescents under 18 years of age should not take this medicine.
This medicine is not effective in children and adolescents aged 10 to 17 years. It is not known whether this medicine is safe and effective in children under 10 years of age.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
In particular, tell your doctor if you are taking digoxin (a medicine used to treat irregular heartbeat and other heart problems). Your doctor may need to check your digoxin blood levels if you are taking it with Sitagliptin Adamed.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
This medicine should not be used during pregnancy.
It is not known whether this medicine passes into breast milk. This medicine should not be used if you are breastfeeding or plan to breastfeed.
This medicine has no or negligible influence on the ability to drive and use machines. However, dizziness and drowsiness have been observed, which may affect the ability to drive and use machines.
Taking this medicine in combination with medicines such as sulfonylurea derivatives and insulin may cause low blood sugar levels (hypoglycemia), which may affect the ability to drive and use machines or work without a safe support for your feet.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially 'sodium-free'.
Take this medicine exactly as your doctor has told you.
If you are not sure, ask your doctor or pharmacist.
The usual recommended dose is:
Your doctor may prescribe this medicine to be taken alone or in combination with other medicines that lower blood sugar levels.
Diet and exercise can help your body use sugar better. While taking Sitagliptin Adamed, it is important to continue with the diet and exercise program recommended by your doctor.
If you have taken more Sitagliptin Adamed than you should, contact your doctor immediately.
If you miss a dose, take it as soon as you remember. However, if you do not remember until it is time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose of this medicine.
Take this medicine for as long as your doctor recommends, so you can keep your blood sugar levels under control. Do not stop taking this medicine without talking to your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
STOP taking Sitagliptin Adamed and contact your doctor immediately if you experience any of the following serious side effects:
If a severe allergic reaction occurs (frequency not known), including rash, hives, blisters on the skin/peeling of the skin, and swelling of the face, lips, tongue, and throat, which may cause difficulty breathing and swallowing, stop taking this medicine and contact your doctor immediately. Your doctor may prescribe a medicine to treat the allergic reaction and another medicine to treat your diabetes.
The following side effects have been reported in patients taking sitagliptin in combination with metformin:
Common (may affect up to 1 in 10 people): low blood sugar levels, nausea, bloating, vomiting
Uncommon (may affect up to 1 in 100 people): abdominal pain, diarrhea, constipation, drowsiness
In patients taking sitagliptin in combination with sulfonylurea derivatives and metformin, the following side effects have been reported:
Very common (may affect more than 1 in 10 people): low blood sugar levels
Common: constipation
In patients taking sitagliptin and pioglitazone, the following side effects have been reported:
Common: bloating, swelling of the hands or feet
In patients taking sitagliptin in combination with pioglitazone and metformin, the following side effects have been reported:
Common: swelling of the hands or feet
In patients taking sitagliptin in combination with insulin (with or without metformin), the following side effects have been reported:
Common: flu
Uncommon: dry mouth
The following side effects have been reported in patients taking sitagliptin alone or in combination with other anti-diabetic medicines in clinical trials or during post-marketing use:
Common: low blood sugar levels, headache, upper respiratory tract infection, stuffy or runny nose, and sore throat
Uncommon: dizziness, constipation, drowsiness
Rare: reduced number of blood platelets
Frequency not known: kidney problems (sometimes requiring dialysis), vomiting, abdominal pain, joint pain, muscle pain, back pain, interstitial lung disease, bullous pemphigoid (a type of blistering skin condition).
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department for Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the blister and carton after 'EXP'. The expiry date refers to the last day of that month.
There are no special storage requirements for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
25 mg tablet: orange, round, biconvex film-coated tablet with '25' embossed on one side.
50 mg tablet: orange, round, biconvex film-coated tablet with '50' embossed on one side.
100 mg tablet: orange, round, biconvex film-coated tablet with '100' embossed on one side.
Blisters (PVC/PVDC/Aluminium)
Packaging containing 28, 98 film-coated tablets in blisters, placed in a cardboard box.
Not all pack sizes may be marketed.
Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów
Adamed Pharma S.A.
ul. Marszałka Józefa Piłsudskiego 5
95-200 Pabianice
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.